Get the Stockscreener App
24.11
2.19%
-0.54
After Hours:
24.11
Amphastar Pharmaceuticals Inc stock is traded at $24.11, with a volume of 790.22K.
It is down -2.19% in the last 24 hours and down -4.44% over the past month.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
See More
Previous Close:
$24.65
Open:
$24.54
24h Volume:
790.22K
Relative Volume:
1.30
Market Cap:
$1.16B
Revenue:
$723.55M
Net Income/Loss:
$157.72M
P/E Ratio:
8.0367
EPS:
3
Net Cash Flow:
$170.15M
1W Performance:
-1.59%
1M Performance:
-4.44%
6M Performance:
-50.09%
1Y Performance:
-43.18%
1-Day Range:
$23.30
$25.02
1-Week Range:
$23.30
$25.36
52-Week Range:
$22.64
$53.95
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
Name
Amphastar Pharmaceuticals Inc
Sector
Phone
909-980-9484
Address
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Compare AMPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
24.11 | 1.16B | 723.55M | 157.72M | 170.15M | 3.00 |
|
ZTS
Zoetis Inc
|
159.27 | 70.23B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.74 | 48.23B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.36 | 48.22B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.93 | 18.57B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
301.42 | 13.29B | 2.76B | 1.11B | 898.10M | 22.77 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-04-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Nov-22-24 | Initiated | Wells Fargo | Equal Weight |
| Mar-05-24 | Initiated | JP Morgan | Overweight |
| Nov-17-23 | Initiated | BofA Securities | Neutral |
| Jul-25-23 | Resumed | Jefferies | Buy |
| Oct-21-22 | Resumed | Jefferies | Buy |
| Jul-29-22 | Initiated | CapitalOne | Overweight |
| Jan-07-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-08-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Oct-05-20 | Upgrade | Northland Capital | Market Perform → Outperform |
| May-01-20 | Initiated | Northland Capital | Outperform |
| Mar-13-19 | Downgrade | Needham | Buy → Hold |
| Mar-13-19 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Aug-10-18 | Reiterated | Needham | Buy |
| Mar-13-18 | Reiterated | Needham | Buy |
| Dec-01-17 | Reiterated | Needham | Buy |
| Nov-09-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-27-17 | Reiterated | Needham | Buy |
| Mar-14-17 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-09-16 | Reiterated | Needham | Buy |
| May-10-16 | Reiterated | Needham | Buy |
| Feb-19-16 | Initiated | Wells Fargo | Outperform |
| Jun-19-15 | Reiterated | Needham | Buy |
| Jun-03-15 | Initiated | Raymond James | Strong Buy |
| Jul-21-14 | Initiated | Needham | Buy |
View All
Amphastar Pharmaceuticals Inc Stock (AMPH) Latest News
Trend Tracker for (AMPH) - news.stocktradersdaily.com
Dimensional Fund Advisors LP Raises Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
U.S. Naloxone Market to Witness Remarkable Growth with Amphastar Pharmaceuticals Inc., Emergent BioSolutions Inc. - openPR.com
Schonfeld Strategic Advisors LLC Buys 33,007 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals to Present at the 2025 Bank of America Health Care Conference - ACCESS Newswire
U.S. Naloxone Market Set to Witness Significant Growth - openPR.com
Amphastar Pharmaceuticals’ Mixed Earnings Call Insights - TipRanks
Amphastar outlines key launches and product growth drivers for 2025 - MSN
43,235 Shares in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Purchased by Aristeia Capital L.L.C. - MarketBeat
Amphastar Pharmaceuticals, Inc. SEC 10-Q Report - TradingView
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2025 Earnings Call Transcript - Insider Monkey
Amphastar Pharmaceuticals Revenue Miss: EPS Exceeds ExpectationsNews and Statistics - IndexBox
Amphastar Pharmaceuticals Reports Q1 2025 Earnings - TipRanks
Amphastar: Q1 Earnings Snapshot - MySA
Compared to Estimates, Amphastar (AMPH) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q1 Sales Targets - Yahoo Finance
Earnings call transcript: Amphastar Q1 2025 misses earnings, stock edges up - Investing.com Australia
Amphastar Q2 2025 slides: strategic shift to proprietary drugs amid growth challenges - Investing.com India
Amphastar Pharmaceuticals (AMPH) Tops Q1 Earnings Estimates - Yahoo Finance
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025 - ACCESS Newswire
Earnings Flash (AMPH) Amphastar Pharmaceuticals Posts Q1 Adjusted EPS $0.74, vs. FactSet Est of $0.69 - marketscreener.com
Earnings Outlook For Amphastar Pharma - Nasdaq
Amphastar Pharmaceuticals to Announce Earnings: What to ExpectNews and Statistics - IndexBox
Amphastar Pharmaceuticals (AMPH) Reports Earnings Tomorrow: What To Expect - Yahoo Finance
Amphastar Pharmaceuticals (AMPH) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Insider Sell: Floyd Petersen Sells Shares of Amphastar Pharmaceuticals Inc (AMPH) - GuruFocus
Raymond James Financial Inc. Acquires Shares of 92,904 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Is the Options Market Predicting a Spike in Amphastar (AMPH) Stock? - MSN
Take off with Amphastar Pharmaceuticals Inc (AMPH): Get ready for trading - Sete News
Adversity is less terrifying than hope: Inovio Pharmaceuticals Inc (INO) - Sete News
Envestnet Asset Management Inc. Sells 2,463 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2025 - Yahoo Finance
Barclays PLC Buys 10,334 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Acquired by Oberweis Asset Management Inc. - MarketBeat
Learn to Evaluate (AMPH) using the Charts - news.stocktradersdaily.com
2 Healthcare Stocks on Our Watchlist and 1 to Be Wary Of - The Globe and Mail
Anaphylaxis Treatment Market Size in 7MM is expected to grow at - openPR.com
Generic Pharmaceuticals Stocks Q4 Teardown: Viatris (NASDAQ:VTRS) Vs The Rest - Yahoo Finance
Amphastar Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference - ACCESS Newswire
Fuller & Thaler Asset Management Inc. Cuts Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stock Position Boosted by Marshall Wace LLP - MarketBeat
Epoch Investment Partners Inc. Decreases Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals Announces Proposed Private Offering of $300.0 Million of Convertible Senior Notes - ACCESS Newswire
Mesirow Institutional Investment Management Inc. Has $14.12 Million Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
JPMorgan Chase & Co. Has $5.70 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Legal & General Group Plc Sells 3,871 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Acquired by LPL Financial LLC - Defense World
Amphastar Pharmaceuticals Inc Stock (AMPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.82%
1.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):